The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Publications hub
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
We’re still confirming the best location for some of our content. Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Loading...
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- (-) Advertising (9)
- (-) Listed medicines (7)
- Prescription medicines (21)
- Therapeutic goods regulation (15)
- Medicine safety (12)
- Scheduling (national classification system) (10)
- Manufacturing (9)
- Safety (9)
- Over the counter (OTC) medicines (8)
- Medical devices safety (7)
- Non-prescription medicines (7)
- Regulatory compliance (7)
- In Vitro Diagnostic medical devices (IVDs) (6)
- Assessed listed medicines (5)
- Registered complementary medicines (5)
- Shortages (4)
- Fees and payments (3)
- Legislation (3)
- Medicinal cannabis hub (3)
- Clinical trials (2)
- Complementary medicines (2)
- Compliance and enforcement hub (2)
- Import and export (2)
- Sunscreens (2)
- Advisory bodies and committees (1)
- Alert/Advisory (1)
- Artificial Intelligence (AI) (1)
- Australian Register of Therapeutic Goods (ARTG) (1)
- Breast implant hub (1)
- Cosmetics (1)
- Disinfectants/Sterilants (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Pharmacovigilance (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
16 result(s) found, displaying 1 to 16
-
PublicationsThis plan outlines our compliance and education priorities for 2024-2025.
-
PublicationsThe strategy outlines the approach we will use to identify, engage with, and educate stakeholders about regulatory requirements and our compliance outcomes.
-
PublicationsOverview of therapeutic goods advertising complaints handling and compliance for 2022-23
-
PublicationsThe TGA Pharmacovigilance Inspection Program (PVIP) metrics report for 2021 is now available.
-
PublicationsOverview of therapeutic goods advertising complaints handling and compliance for 2021-22
-
PublicationsOutcomes following review of consultation submissions
-
PublicationsThe PVIP aims to strengthen and broaden the TGA's post-market monitoring activities and protect public health
-
PublicationsThe Australian Government has accepted all 22 recommendations
-
PublicationsOverview of therapeutic goods advertising complaints handling and compliance for 2019-20
-
PublicationsFinal Report on the impact of advertising reforms from the Expert Panel Review of Medicines and Medical Devices Regulation, and other initiatives
-
PublicationsThe independent review is complete and the report now published.
-
PublicationsIn 2019, the TGA conducted 10 pharmacovigilance inspections of Australian medicine sponsors
-
PublicationsThe TGA has conducted a safety review on coumarin in topical listed medicines
-
PublicationsOverview of therapeutic goods advertising complaints handling and compliance for the year 2018-19
-
PublicationsStatistics from inspections conducted from 1 September 2017 to 31 December 2018
-
PublicationsThis Code supersedes the November 1991 edition of the Australian Code of Good Wholesaling Practice for Therapeutic Goods for Human Use.